Active targeting of mesoporous silica drug carriers enhances γ-secretase inhibitor efficacy in an in vivo model for breast cancer.
Nanomedicine (Lond)
; 9(7): 971-87, 2014 May.
Article
in En
| MEDLINE
| ID: mdl-23898823
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Triazines
/
Breast Neoplasms
/
Drug Carriers
/
Silicon Dioxide
/
Enzyme Inhibitors
/
Amyloid Precursor Protein Secretases
/
Nanoparticles
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Nanomedicine (Lond)
Year:
2014
Type:
Article
Affiliation country:
Germany